BENESSI Trademark

Trademark Overview

On Tuesday, May 25, 2021, a trademark application was filed for BENESSI with the United States Patent and Trademark Office. The USPTO has given the BENESSI trademark a serial number of 90734428. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Laboratorios Farsiman, S.A.. The BENESSI trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines
benessi

General Information

Serial Number90734428
Word MarkBENESSI
Filing DateTuesday, May 25, 2021
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7279868
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements

Goods and ServicesDevelopment of pharmaceutical preparations and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 20, 2021
Primary Code042
First Use Anywhere DateWednesday, December 15, 2021
First Use In Commerce DateWednesday, December 15, 2021

Trademark Owner History

Party NameLaboratorios Farsiman, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCholoma, Cortés
HN
Party NameLaboratorios Farsiman, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCholoma, Cortés
HN
Party NameLaboratorios Farsiman, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCholoma, Cortés
HN

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 12, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 11, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023ASSIGNED TO LIE
Wednesday, July 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, June 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 11, 2023USE AMENDMENT FILED
Monday, June 5, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 11, 2023TEAS STATEMENT OF USE RECEIVED
Friday, October 7, 2022ASSIGNED TO EXAMINER
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 21, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 21, 2022SOU EXTENSION 1 FILED
Tuesday, June 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 5, 2022ASSIGNED TO EXAMINER
Friday, August 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 28, 2021NEW APPLICATION ENTERED

Related Keywords

benessi medicines preparations pharmaceutical development